Skip to content
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Search
Read about Endologix
in the news
Embrace the evidence.
The Latest:
Jul 9
Endologix Announces that Scott Huennekens Joins Board of Directors
See Release
All News
Archives
All
2025
2024
2023
2022
2021
Jun 8
Endologix receives FDA Approval of the DETOUR™ System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD.
May 23
Endologix Announces 150th Patient Enrolled in JAGUAR Randomized Controlled Trial
May 5
Endologix Wins “Medical Device Engineering Breakthrough” Award in 7th Annual MedTech Breakthrough Awards Program
Apr 27
Five-Year Results of the LEOPARD Trial published in the Journal of Vascular Surgery (JVS)
Dec 7
Endologix Receives FDA Approval of PMA Supplement for AFX2 System
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
